EUVIMEDEUVIMED entdecken
Crossref

Cynaropicrin attenuates inflammatory cytokines in LPS‐induced RAW264.7 cells and ovalbumin‐induced asthmatic mice

Junyan Chen, Xiaohong Liu

Journal of Biochemical and Molecular Toxicology · 2024

DOI: 10.1002/jbt.23836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Junyan Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Asthma, Lipopolysaccharides, Ovalbumin, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines the anti‐inflammatory activity of cynaropicrin against lipopolysaccharide (LPS) in vitro and ovalbumin (OVA)‐challenged asthma in mice. Cynaropicrin's antimicrobial effects were tested on Escherichia coli (E. coli) and Streptococcus pyogenes (S. pyogenes) using the disc diffusion technique. Cytotoxicity was assessed with an (3‐(4, 5‐dimethylthiazolyl‐2)‐2, 5‐diphenyltetrazolium bromide) assay. The anti‐inflammatory property was evaluated in LPS‐induced RAW264.7 cells, while OVA‐challenged asthmatic mice were treated with 10 mg/kg of cynaropicrin. Key inflammatory and antioxidant markers were quantified, and lung histology was examined to confirm therapeutic roles. The antimicrobial studies proved that cynaropicrin effectively inhibited the growth of E. coli and S. pyogenes . Cynaropicrin displayed no cytotoxicity on RAW264.7 cells. Furthermore, it significantly inhibited inflammatory cytokine synthesis upon LPS induction. Cynaropicrin treatment decreased the inflammatory cell counts and also suppressed specific allergic markers in OVA‐challenged mice. It also decreased nitric oxide and myeloperoxidase levels and reduced pulmonary edema. Cynaropicrin increased antioxidant levels and decreased proinflammatory cytokines in the asthmatic mice. Lung histological examination confirms the ameliorative potency of cynaropicrin against OVA‐induced asthmatic pulmonary inflammation in mice. Our findings suggest cynaropicrin possesses significant ameliorative potency against allergen‐induced pulmonary inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaLipopolysaccharidesOvalbuminCytokinesAnimalsMiceRAW 264.7 CellsSesquiterpenesMice, Inbred BALB CEscherichia coliStreptococcus pyogenesAnti-Inflammatory AgentsMaleFemaleLactones

Stichwörter der Autor:innen

RAW264.7 cellsairway infectionallergic asthmacynaropicrininflammation

Substanzen

LipopolysaccharidesOvalbuminCytokinescynaropicrinSesquiterpenesAnti-Inflammatory AgentsLactones

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Zitieren

APA

Chen, J., & Liu, X. (2024). Cynaropicrin attenuates inflammatory cytokines in LPS‐induced RAW264.7 cells and ovalbumin‐induced asthmatic mice. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23836

Vancouver

Chen J, Liu X. Cynaropicrin attenuates inflammatory cytokines in LPS‐induced RAW264.7 cells and ovalbumin‐induced asthmatic mice. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23836

BibTeX
@article{Chen2024,
  author = {Chen, Junyan and Liu, Xiaohong},
  title = {Cynaropicrin attenuates inflammatory cytokines in LPS‐induced RAW264.7 cells and ovalbumin‐induced asthmatic mice},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  doi = {10.1002/jbt.23836}
}
Kostenlos starten →